NICE recommends Viekirax (ombitasvir + paritaprevir + ritonavir) + Exviera (dasabuvir) for treatment of genotype 1 Hepatitis C- AbbVie
The National Institute for Health and Care Excellence (NICE) recommends Viekirax (ombitasvir + paritaprevir + ritonavir), from AbbVie, with or without dasabuvir (Exviera), for treatment of genotype 1b Hepatitis C patients without cirrhosis or with compensated cirrhosis (plus ribavirin) and for genotype 1a patients over 12 weeks without cirrhosis (plus ribavirin).
Cost of the combination is £10,733 for a 28-day course. Total costs over 12 weeks and 24 weeks are £32,200 and £64,400 respectively. Cost of dasabuvir (if needed) is £933 per 28 day pack and £3,100 and £6,200 for 12 weeks and 24 weeks respectively.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins